Yiran Zhang
Overview
Explore the profile of Yiran Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
313
Citations
2224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang Z, Zhang Z, Zhao J, Zhang F, Zhang Y, Wen Y, et al.
Int J Biol Macromol
. 2025 Mar;
:142113.
PMID: 40089239
Osteosarcoma (OS) is one of the most prevalent bone malignancies with a poor prognosis. Various types of programmed cell death patterns can influence cancer progression and response to treatment. We...
2.
Wang L, Wei L, Wei J, Zhu Y, Zhao H, Zhang Y, et al.
Int J Biol Macromol
. 2025 Mar;
307(Pt 1):141577.
PMID: 40054797
Polyetheretherketone (PEEK) has emerged as a promising material for bone substitution; however, its limited osseointegration hinders its clinical applications. This research employs a porous structural design alongside surface modification techniques...
3.
Lin M, Du Z, Guo D, Zhang Y, Dan J
Proc Natl Acad Sci U S A
. 2025 Mar;
122(10):e2421594122.
PMID: 40048272
Zygotic genome activation (ZGA) confers to the mouse two-cell (2C) embryo a unique transcriptional profile characterized by transient up-regulation of many totipotency-related genes and retrotransposons. Intriguingly, those genes are duplicated...
4.
Zhou B, Zhang Y, Han S, Zhang J, Song L, Wang H
Echocardiography
. 2025 Mar;
42(3):e70120.
PMID: 40029146
Purpose: Numerous recovered COVID-19 patients exhibit persistent cardiovascular symptoms. However, the degree of myocardial dysfunction and its associated risk factors remain unclear. This study aims to evaluate myocardial dysfunction in...
5.
Zeng Q, Li J, Liu Y, Zhang Y, Su H, Tu F
Drug Des Devel Ther
. 2025 Mar;
19:1323-1332.
PMID: 40026333
Purpose: Sufentanil is a potent opioid analgesic frequently used to suppress the tracheal intubation response. The pathophysiological changes of obesity may affect opioid pharmacokinetics and increase the risk of opioid-induced...
6.
He G, Yu Y, Wang J, Zhang Y, Lu H, Zhu Y, et al.
Cardiovasc Intervent Radiol
. 2025 Feb;
PMID: 39971794
Purpose: The purpose of this study is to investigate whether patients with symptomatic severe intracranial atherosclerotic stenosis (ICAS) and downstream perfusion deficit could benefit from adding percutaneous transluminal angioplasty and...
7.
Chen H, Yao X, Yang C, Zhang Y, Dong H, Zhai J, et al.
J Transl Med
. 2025 Feb;
23(1):186.
PMID: 39953591
Lung cancer (LC) remains the leading cause of cancer death globally. Recent reports have suggested that circulating microbial nucleic acids have potential as promising biomarkers for cancer liquid biopsies. However,...
8.
Nie Y, Zhang Y, Liu B, Meng H
Obes Surg
. 2025 Feb;
35(3):808-822.
PMID: 39948306
Background: Suboptimal initial clinical response (SICR) and weight gain recurrence (WGR) are challenging issues following bariatric surgery. Recently, the promising weight loss effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs)...
9.
Dong Q, Fu H, Li W, Ji X, Yin Y, Zhang Y, et al.
Bone Res
. 2025 Jan;
13(1):20.
PMID: 39885145
The delicate balance between bone formation by osteoblasts and bone resorption by osteoclasts maintains bone homeostasis. Nuclear receptors (NRs) are now understood to be crucial in bone physiology and pathology....
10.
Otkur W, Zhang Y, Li Y, Bao W, Feng T, Wu B, et al.
Life Metab
. 2025 Jan;
3(6):loae021.
PMID: 39873004
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a metabolic disease that can progress to metabolic dysfunction-associated steatohepatitis (MASH), cirrhosis, and cancer. The zonal distribution of biomolecules in the liver is...